VALIDATION OF BRIEF COGNITIVE TESTS in mild cognitive impairment, Alzheimer’s disease and dementia with Lewy bodies
نویسندگان
چکیده
....................................................................................................... 8 Sammanfattning .......................................................................................... 9 Abbreviations ............................................................................................ 11 1 Introduction to neurodegenerative diseases .................................... 13 1.1 Alzheimer’s disease ................................................................................ 13 1.1.1 Neuropsychological prediction .......................................................... 13 1.1.2 Cognitive impairment ........................................................................ 14 1.1.3 Treatment ........................................................................................... 14 1.2 Dementia with Lewy bodies ................................................................... 15 1.3 Other dementias ...................................................................................... 15 2 Brief cognitive tests ............................................................................. 17 2.1 A Quick Test of Cognitive Speed .......................................................... 17 2.1.1 Administration ................................................................................... 18 2.1.2 Scoring ............................................................................................... 18 2.1.3 Reliability .......................................................................................... 19 2.1.4 Demographic effects .......................................................................... 19 2.1.5 Correlation with brain structures ....................................................... 20 2.1.6 Associations with other measures ..................................................... 20 2.1.7 Normative data .................................................................................. 22 2.1.8 Clinical findings ................................................................................ 22 2.1.9 Comments .......................................................................................... 23 2.2 Clock drawing ......................................................................................... 24 2.2.1 Administration ................................................................................... 26 2.2.2 Scoring ............................................................................................... 27 2.2.3 Reliability .......................................................................................... 27 2.2.4 Demographic effects .......................................................................... 27 2.2.5 Correlation with brain structures ....................................................... 29 2.2.6 Associations with other measures ..................................................... 30 2.2.7 Normative data .................................................................................. 30 2.2.8 Different types of errors .................................................................... 31
منابع مشابه
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up
Introduction: Early identification of Alzheimer’s disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI) to AD. Methods: At a memory clinic, 133 patients with MCI were followed until development of dementia or until they had b...
متن کاملComparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
INTRODUCTION Early identification of Alzheimer's disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI) to AD. METHODS At a memory clinic, 133 patients with MCI were followed until development of dementia or until they had b...
متن کاملAnalysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
BACKGROUND AND PURPOSE The substantia innominata (SI) contains the nucleus basalis of Meynert, which is the major source of cholinergic input to the cerebral cortex. We hypothesized that degeneration of the SI and its relationship to general cognitive performance differs in amyloidopathy and synucleinopathy. METHODS We used magnetic resonance imaging (MRI)-based volumetric analysis to evaluat...
متن کاملValidation of Addenbrooke's cognitive examination for detecting early dementia in a Japanese population.
There is a clear need for brief, but sensitive and specific, cognitive screening instruments for dementia. We assessed the diagnostic accuracy of the Japanese version of Addenbrooke's Cognitive Examination (ACE) in identifying early dementia in comparison with the conventional Mini-Mental State Examination (MMSE). Standard tests for evaluating dementia screening tests were applied. A total of 2...
متن کاملRelationship of Retinal Nerve Fibers Layer Thickness with Mild Cognitive Impairment and Alzheimer's Dementia
Background and Objective: In this study, the thickness of the retinal nerve fibers layer(RNFL) was compared among patients with mild cognitive impairment, Alzheimer's dementia, and healthy individuals (controls) using Optical Coherence Tomography (OCT) device. Materials and Methods: This case-control study was conducted on 30 patients diagnosed with mild cognitive impairment and 31 healthy sub...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016